Christoph Brackmann, Chief Financial Officer at NovoCure Ltd (NVCR), bought 30,000 shares at $11.63 ($348K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.50 | 5,000 | $58K | 16.5% |
| 2 | $11.60 | 5,000 | $58K | 16.7% |
| 3 | $11.63 | 10,000 | $116K | 33.4% |
| 4 | $11.63 | 10,000 | $116K | 33.4% |
| Total | $11.60 avg | 30,000 | $348K | 100% |